Product Description
GSK-3326595 is a potent and selective protein arginine methyltransferase 5 (PRMT5) inhibitor (IC50 = 6.2 nM) that induces cell death in a broad range of solid and hematologic tumor cell lines. It also displays potent anti-tumor activity in vivo in animal models, including in preclinical models of myeloid malignancies
GSK-3326595 is a potent and selective protein arginine methyltransferase 5 (PRMT5) inhibitor (IC50 = 6.2 nM) that induces cell death in a broad range of solid and hematologic tumor cell lines. It also displays potent anti-tumor activity in vivo in animal models, including in preclinical models of myeloid malignancies
Biovision | B3321 | GSK-3326595 DataSheet
Alternate Name/Synonyms: Pemrametostat EPZ-015938 S)-6-((1-acetylpiperidin-4-yl)amino)-N-(3-(3,4-dihydroisoquinolin-2(1H)-yl)-2-hydroxypropyl)pyrimidine-4-carboxamide
Appearance: Crystalline solid
Formulation:
CAS Number: 1616392-22-3
Structure Available?: Yes
Peptide sequence: N/A
Salt Form: No
Molecular Formula: C₂₄H₃₂N₆O₃
Molecular Weight: 452.56
Cell-Permeable?: TRUE
Purity: ≥98% by HPLC
Solubilities: >25 mg/ml DMSO
Handling: Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.
Country of Origin: USA
Tag Line: A potent protein arginine methyltransferase 5 inhibitor
MDL Number:
PubChem CID: 90241742
SMILES: CC(=O)N1CCC(CC1)NC2=NC=NC(=C2)C(=O)NCC(CN3CCC4=CC=CC=C4C3)O
InChi: InChI=1S/C24H32N6O3/c1-17(31)30-10-7-20(8-11-30)28-23-12-22(26-16-27-23)24(33)25-13-21(32)15-29-9-6-18-4-2-3-5-19(18)14-29/h2-5,12,16,20-21,32H,6-11,13-15H2,1H3,(H,25,33)(H,26,27,28)/t21-/m0/s1
InChi Key: JLCCNYVTIWRPIZ-NRFANRHFSA-N